Metoclopramide drugs, including Reglan, are used for the treatment of acid reflux and are intended for short-term use (less than 12 weeks). Since Reglan increases the muscle contractions in the upper digestive tract, this also increases the speed at which the stomach contents empty into the intestines.

In February, 2009, the FDA notified manufacturers of Reglan that they must add a warning to their drug labels regarding the risk of the drug’s long-term or high dose use as follows: “Chronic use of metroclopramide (Reglan) has been linked to tardive dyskinesia, which may include involuntary and repetitive movements of the body, even after the drugs are no longer taken.”

Tardive means a condition has the tendency to appear late. Dyskinesia refers to the involuntary nature of muscular movements or the difficulty in performing voluntary muscular movement. Tardive dyskinesia is a neurological condition that has been reported in many patients who have been prescribed Reglan. Symptoms include: rapid eye blinking, involuntary grimacing, involuntary lip and tongue movement, tongue protrusion, rapid movement in the extremities (arms and legs) and rapid eye blinking. These symptoms can continue long after the use of Reglan has been discontinued.

The attorneys at Schuler, Halvorson, Weisser and Zoeller, PA have handled cases throughout the entire state of Florida and have extensive experience in class action lawsuits. If you or a loved one have been seriously injured after taking Reglan, please do not hesitate to contact one of the lawyers at Schuler, Halvorson, Weisser and Zoeller, PA for a free initial consultation.